SMTL ID : 3npc.1 (2 other biounits)

Crystal structure of JNK2 complexed with BIRB796

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.35 Å

Oligo State

monomer

Ligands

1 x B96: 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA(Non-covalent)

B96.1: 21 residues within 4Å: Chain A: I.32, Q.37, V.40, A.53, K.55, R.69, R.72, E.73, L.76, L.77, I.86, L.106, M.108, E.109, L.110, M.111, L.142, H.149, L.168, D.169, F.170 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:A.53, A:K.55, A:K.55, A:R.69, A:E.73, A:L.76, A:L.77, A:I.86, A:I.86, A:L.106, A:L.142, A:F.170 Hydrogen bonds: A:E.73, A:E.73, A:M.111, A:D.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kuglstatter, A. et al., X-ray crystal structure of JNK2 complexed with the p38alpha inhibitor BIRB796: Insights into the rational design of DFG-out binding MAP kinase inhibitors. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-08-11

Peptides

Mitogen-activated protein kinase 9: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 9

Related Entries With Identical Sequence